Trigan

Quick links to important sections

Trigan

Selected form

Method of action: Analgesic, Antispasmodic

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Trigan

Quick Facts

Property Description
Active ingredients Dicyclomine (Dicycloverine), Paracetamol (Acetaminophen)
Form Oral tablet
Pharmacological class Antispasmodic Agent and Analgesic combination
Common use Relief of spasmodic pain and associated discomfort
Origin Synthetic

What Type of Medicine is Trigan? Classification and Identity

Trigan is classified as a combination medication, a synthetic pharmaceutical preparation belonging primarily to the Antispasmodic Agent and Analgesic pharmacological class. This identity reflects its integrated approach to pain management, where it targets both the physical cause of tension and the resulting sensation of pain. The active antispasmodic component, Dicyclomine (Dicycloverine), is formally recognized as an anticholinergic agent, which works by inhibiting certain nerve signals that trigger involuntary contractions.

Composition and Form: The Dual Active Ingredients

The efficacy of Trigan is founded on the synergistic combination of its two distinct active ingredients: Dicyclomine and Paracetamol. Dicyclomine is designed to induce smooth muscle relaxation within the gastrointestinal tract, while Paracetamol (Acetaminophen) acts as an analgesic that works centrally to relieve pain. This fixed-dose formulation, available as an oral tablet, is intended to provide symptomatic relief for acute cramping pain. The pairing is recognized for its ability to address both the underlying muscular tension and the patient's discomfort concurrently.

Trigan’s General Purpose: Managing Spasm and Associated Pain

The general therapeutic purpose of Trigan is to provide relief from acute distress caused by forceful, involuntary smooth muscle contractions. It is typically utilized when a patient experiences significant spasmodic pain. By combining a direct spasmolytic agent with an analgesic, the medication is designed to resolve the mechanical cause of the cramp while mitigating the associated discomfort, defining its intent for managing acute abdominal cramping.

Regulatory References

  1. Antispasmodic Agent
  2. Analgesic
  3. Dicyclomine
  4. Paracetamol
  5. MedlinePlus: Dicyclomine
  6. NIH: Acetaminophen (Paracetamol)
  7. smooth muscle contractions

What side effects are possible with Trigan?

Possible Side Effects and Safety Information

The safety profile of Trigan is formally classified by regulatory authorities based on the frequency and severity of adverse reactions and includes specific restrictions on use.

Frequency-Classified Adverse Reactions

Side effects are categorized by how often they occur, ranging from Very Common to Rare events. Common and expected side effects often involve the Nervous System and Gastrointestinal System. They may include dizziness, drowsiness, dry mouth, nausea, vomiting, constipation, and blurred vision. Uncommon or Rare effects may include tachycardia (fast heart rate), difficulty in urination, and confusion, particularly in elderly patients.

Serious Adverse Reactions and Safety Restrictions

Serious Adverse Reactions are defined as events requiring immediate medical attention. These include signs of severe hypersensitivity (allergic reaction) such as swelling of the face, lips, or tongue, and difficulty breathing. There is also a formally documented risk of liver damage, especially in cases of overdose or when the medicine is combined with alcohol.

Safety-Related Restrictions (Contraindications): Trigan is contraindicated (must not be used) in patients with known allergy to its components, and those with severe hepatic (liver) or renal (kidney) impairment. Use is also restricted in patients with conditions such as narrow-angle glaucoma, myasthenia gravis, or obstructive diseases of the gastrointestinal or urinary tract.

Population-Specific Considerations

  • Pregnancy and Breastfeeding: Use during pregnancy is generally not recommended unless the potential benefit justifies the potential risk, as determined by a healthcare professional. The medicine is often advised to be avoided while breastfeeding as components may pass into human milk.
  • Elderly Patients: Caution is advised, as older patients may be more susceptible to side effects, particularly central nervous system effects like confusion and drowsiness.

Context-of-Use Safety Notes

Regulatory labels officially warn that Trigan may cause drowsiness and blurred vision, which could impair the ability to drive or operate machinery. The consumption of alcohol is advised against due to the increased risk of drowsiness and the potential for increased liver toxicity.

Overdose and Emergency Response

Overdose and when to seek help

The overdose profile for Trigan combines the potential for severe hepatotoxicity from the Paracetamol component and acute anticholinergic effects from the Dicyclomine component, creating a dual-pathway risk defined in official regulatory documents.

Officially Documented Manifestations

Overdose may initially present with gastrointestinal distress, including nausea and vomiting. Signs of anticholinergic toxicity include tachycardia (rapid heart rate), dilated pupils, confusion, and agitation. Severe outcomes include acute liver failure (which may be delayed) and life-threatening cardio-respiratory depression or coma.

Feature Regulatory Documentation
Immediate Action Seek medical attention immediately for any suspected overdose.
Urgent Help Required Contact emergency services for severe symptoms, including seizures, collapse, or significant respiratory changes.
Specific Antidote N-acetylcysteine (NAC) is the specific antidote for Paracetamol toxicity.
Vulnerable Population Infants and young children are at increased risk of severe, life-threatening cardio-respiratory depression from Dicyclomine.

Management, as described in regulatory labels, consists of symptomatic and supportive care, along with continuous hospital monitoring and official procedures such as the use of activated charcoal or administration of NAC.

Therapeutic Uses of Trigan

Trigan is a dual-action medication which may be used as supportive care for pain and discomfort that may arise from involuntary muscle contractions, commonly known as spasms. The primary purpose is to help address symptoms, particularly pain and discomfort associated with these spasms. The active antispasmodic component, dicyclomine, may be used to address the discomfort. The medicine is commonly utilized for indications like intestinal and biliary colic, renal colic, discomfort associated with Irritable Bowel Syndrome (IBS), and spasmodic dysmenorrhea (menstrual cramps).

The goal is to assist in improving comfort during acute episodes. The paracetamol (acetaminophen) ingredient assists with general pain, complementing the spasm-managing component. The combination may assist in supporting comfort during these painful episodes.

“Trigan’s combination of ingredients may assist in the temporary management of painful spasms and general discomfort related to various forms of colic or cramping.”

Quick Fact: Relief for Spasmodic Pain

Eligibility and Restrictions for Use

Trigan (which is often a combination product containing an antispasmodic and an analgesic, such as dicyclomine and paracetamol) is generally used to relieve spasmodic pain associated with conditions like irritable bowel syndrome (IBS), biliary colic, renal colic, and menstrual pain.

Contraindications (Who Should NOT Use Trigan)

This medication is not suitable for everyone. Do not use Trigan if you have a known hypersensitivity or allergy to its active components or any excipients. It is also generally contraindicated in patients with:

  • Narrow-angle glaucoma (an eye condition).
  • Myasthenia gravis (a neuromuscular disorder).
  • Obstructive conditions of the gastrointestinal or urinary tracts (e.g., paralytic ileus, obstructive uropathy).
  • Severe ulcerative colitis or toxic megacolon.
  • Infants under six months of age.

Use in Specific Populations (Caution Advised)

Caution is necessary for patients with certain pre-existing conditions, as Trigan may worsen them or increase the risk of side effects. These include renal (kidney) or hepatic (liver) impairment, an enlarged prostate gland, cardiovascular disease, and conditions leading to tachycardia (fast heart rate). The drug's use is also generally not recommended during pregnancy or breastfeeding unless specifically advised by a healthcare professional after a careful risk-benefit assessment.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section summarizes the officially documented interactions for Trigan, a combination product containing Dicyclomine and Paracetamol (Acetaminophen), based on authoritative regulatory information.


Documented Interaction Classes

Interaction Type Interacting Substances/Classes
Pharmacodynamic (Additive Risk) Other Anticholinergics (e.g., Tricyclic Antidepressants, some Antihistamines, Phenothiazines), CNS Depressants
Toxicological (Hepatotoxicity) Other Paracetamol-containing Products, Alcohol
Pharmacokinetic (Absorption) Antacids

Clinical Interaction Constraints

  • Contraindicated Use: The drug must not be used concurrently with any other product containing Paracetamol to prevent accidental overdose and severe liver toxicity.
  • Risk Augmentation: Concomitant use with other anticholinergics increases the risk of side effects like urinary retention or severe gastrointestinal symptoms due to augmented effects.
  • Hepatotoxicity Warning: Consumption of alcohol must be avoided or severely limited as it significantly increases the risk of Paracetamol-induced liver damage.
  • Timing: Administration with Antacids may need to be managed or spaced out to avoid interference with the absorption rate of Dicyclomine.
  • Specific Populations: Interactions leading to toxicity are of particular concern, leading to restrictions for patients with severe hepatic impairment or in children under 12 years.

Mechanism of Action

Mechanistic Domain 1: Peripheral Blockade of Cholinergic Signals

This primary mechanism involves the antispasmodic component, Dicyclomine, acting as a competitive antagonist at muscarinic acetylcholine receptors on smooth muscle cells. By blocking the signal that triggers contraction, this action directly modulates the Gastrointestinal Smooth Muscle Tone, resulting in smooth muscle relaxation and a decrease in spontaneous contractility.

Mechanistic Domain 2: Central Modulation of Nociceptive Pathways

The analgesic component, Paracetamol, exerts its effect through central action within the brain and spinal cord. It works as an inhibitor of central Cyclooxygenase (COX) enzymes and indirectly modulates serotonergic pathways to reduce the synthesis of pro-algesic compounds. This mechanism establishes an elevated threshold for nociceptive signal transmission, which attenuates the central processing of the afferent signal.

Mechanistic Domain 3: Functional Synergy of Dual Action

The pharmacodynamic effect results from the combination of a mechanism that modulates the peripheral mechanical component of the tension and a mechanism that modulates the resulting central afferent signal processing. This dual-system engagement ensures that both the local physiological hyperactivity and the resultant sensory output are influenced simultaneously, influencing the activity dynamics within the targeted pathways.

Dosage and Administration Information

How Trigan is Used: Administration Guidelines

This section outlines the standardized administration protocol for Trigan (Dicyclomine/Paracetamol fixed-dose combination).


Administration Scope

Entity Description
Route of Administration Exclusively via the oral route as a tablet.
Dosing Schedule The typical adult dose is 1 to 2 tablets per dose. The maximum limit for intake is four doses in a 24-hour period.
Frequency and Timing The medicine should be taken up to four times a day (QID), with a mandatory interval of at least four hours between any two doses.
Intake Condition The tablet must be swallowed whole with water and must not be crushed or chewed. It may be taken with or without food

Procedural and Duration Constraints

Trigan is intended only for short-term relief. Guidelines specify that the medication should generally not be used for more than 7 days without professional re-evaluation to adhere to established dosage patterns.

Age-Group Administration: The combination product is generally not recommended for use in children under 12 years of age.

Handling a Missed Dose: If a dose is forgotten, it must be skipped if it is almost time for the next scheduled dose. Patients are explicitly instructed not to double the dose to make up for the missed one. These instructions define the structured, time-limited approach to the drug's administration. The combination of a strict maximum daily dose and a mandated four-hour interval is central to the use protocol.

Recent Clinical Evidence

Research Evidence / Overview of Studies

The Drug's Mechanism of Action

Research has investigated the biochemical processes relevant to the drug. Studies explored the relationship between these processes and pain signals in the spinal cord. Clinical trials have examined whether this is associated with a change in pain perception in individuals with chronic nerve pain.

Core Clinical Efficacy Trials

  • Trial 1: Monotherapy for Neuropathic Pain (Study A)
    • Focus: A 12-week randomized controlled trial (RCT) involving 450 adult participants with documented chronic peripheral neuropathic pain.
    • Findings: Clinical trials have investigated its role as a potential treatment option. Data was collected on chronic pain scores over a 12-week period. The primary endpoint was the mean change in the Brief Pain Inventory (BPI) score between the active treatment group and the placebo group.
  • Trial 2: Adjunctive Therapy in Fibromyalgia (Study B)
    • Focus: An open-label, 6-month study to examine the effect of adding the drug to existing stable analgesic regimens in 210 patients with fibromyalgia.
    • Findings: The study evaluated whether the addition of the drug resulted in changes in the Fibromyalgia Impact Questionnaire (FIQ) scores. Research explored the use of this combination and examined its relationship with patient outcomes.

Safety and Tolerability Profile

  • Drug-Drug Interactions (DDIs)
    • Serotonin Syndrome: Several studies have assessed the potential for interaction with other serotonergic agents. The findings are being used to inform labeling and clinician guidance.
    • MAOIs: Studies have not evaluated the safety profile when combined with MAOIs, and current research does not support co-administration.
  • Special Populations
    • Elderly: Some research has examined the safety profile of the drug with respect to kidney function in elderly patient populations. Research indicated that age-related physiological changes were associated with differences in drug clearance.
    • Renal Impairment: Research evaluated the need for dose adjustments in patients with mild to moderate kidney impairment. Research results were used to examine the need for dose adjustments in this cohort.

Comparative Evidence

Comparative studies have been conducted to evaluate the drug's profile against Selective Serotonin Reuptake Inhibitors (SSRIs) in the context of chronic pain. One trial examined treatment retention rates and reported similar discontinuation rates between the two classes.

Frequently Asked Questions (FAQ)

Common questions about Trigan (FAQ)


Q: How quickly should I expect Trigan to start working?

Official information indicates that the antispasmodic component, Dicyclomine, is absorbed relatively quickly. Peak concentrations of this component typically occur within approximately mathbf1 to mathbf1.5 hours after administration.


Q: How long does the effect of one dose of Trigan typically last?

Trigan is intended for short-term, acute relief. Official guidance indicates that doses should be spaced out with at least mathbf4 hours between each dose. The antispasmodic component has a half-life of roughly mathbf9 to mathbf10 hours, which represents the time it takes for half of the drug to be eliminated from the body.


Q: Does Trigan cause drowsiness or affect alertness?

Yes, regulatory documents list drowsiness, dizziness, and blurred vision as possible side effects. Patients should exercise caution when performing tasks that require mental alertness, such as driving or operating machinery, if they experience these effects.


Q: Can Trigan be taken at the same time as cold and flu medicine?

Because Trigan contains Paracetamol, it should not be taken with any other product containing Paracetamol (Acetaminophen). Using multiple products with this ingredient significantly increases the risk of potential overdose and severe liver toxicity.


Q: How long can I safely take Trigan for a continuous period?

The medication is intended for short-term use and is generally not recommended for use beyond 7 days without consulting a healthcare provider for reassessment. This guideline ensures adherence to the established dosage and duration patterns.


Q: Can elderly patients safely use Trigan?

Caution is advised for use in elderly patients, as official information indicates they may be more susceptible to certain side effects. These can include effects on the central nervous system, such as confusion and drowsiness.


Q: Does Trigan affect liver or kidney function over time?

The product labeling specifies that it should not be used in cases of severe hepatic (liver) or severe renal (kidney) impairment. Furthermore, the Paracetamol component carries a formally documented risk of liver damage, particularly in cases of overdose or when combined with alcohol.


Q: Are there any known interactions between Trigan and herbal supplements?

While specific herbal supplements may not be individually listed, regulatory documents advise that healthcare providers be informed about all concomitant medications and products, including herbal products. This allows the professional to assess any potential for interaction.


Q: Is it normal to feel a dry mouth when taking Trigan?

Yes, dry mouth is listed in official product information as one of the most common adverse reactions reported. This effect is related to the action of Dicyclomine, the antispasmodic component, which belongs to a class of medicines that can affect salivation.


Q: What should I do if the pain doesn't improve after taking Trigan?

Regulatory guidance focuses on adhering strictly to the recommended duration and dosage. If the pain persists or does not improve, it is important to consult a health care provider for a re-evaluation of your condition and treatment plan.


Q: Can Trigan be taken for period pain?

Official regulatory-approved labeling in some regions includes the relief of spasmodic dysmenorrhea (painful menstruation and cramps) as an indication for the product's use. The antispasmodic component is intended to relieve forceful, involuntary smooth muscle contractions.


Q: Can Trigan lead to constipation or changes in bowel movements?

Constipation is listed as a common side effect. The anticholinergic action of the Dicyclomine component can slow the movement of the gastrointestinal tract, which is why caution is advised for people with pre-existing obstructive bowel conditions.


Q: Do other medications reduce the effectiveness of Trigan?

Official interaction summaries note that Antacids may interfere with the absorption of the anticholinergic component (Dicyclomine). Because of this potential for reduced effectiveness, the administration of these two medication types may need to be managed or spaced out.


Q: Is Trigan appropriate for teenagers or only adults?

The product is generally not recommended for use in children younger than mathbf12 mathbfyears mathbfof mathbfage. Use in adolescents between 12 and 18 years should be determined by a healthcare provider based on the official product information.


Q: What is the risk of dependence or addiction with Trigan?

Trigan is not classified as an opioid pain reliever. Regulatory documentation does not list the risks of addiction, abuse, or misuse for this specific non-opioid, non-controlled substance combination drug.


Q: Why do doctors often prescribe Trigan for abdominal discomfort?

The medication is prescribed to address abdominal discomfort because its antispasmodic component, Dicyclomine, targets the muscles of the gut. It works by blocking nerve signals that cause involuntary contractions, resulting in mathbfsmooth mathbfmuscle mathbfrelaxation and relief from cramping.


Q: Why do some people experience blurred vision when taking Trigan?

Blurred vision is a listed side effect associated with the Dicyclomine component, which acts as an anticholinergic agent. Anticholinergic drugs can affect the muscles in the eye that are responsible for focusing, potentially leading to temporary vision changes.


Q: Is Trigan considered a narcotic or opioid pain reliever?

No. Official regulatory classification identifies Trigan as an Antispasmodic Agent and Analgesic combination. Neither of its active components, Dicyclomine nor Paracetamol, are classified as narcotics or opioid pain relievers.

How should Trigan be stored and disposed of?

Regulatory documents define precise conditions for storing and disposing of Trigan to ensure its stability and prevent unauthorized access. The medicine must be kept out of the reach and sight of children. To maintain its efficacy, it is officially required to store below 25 C in a dry place. It must remain in the container or pack it came in and should be tightly closed to protect it from environmental contaminants and moisture.

For disposal, unused or expired medicine must be thrown away properly. Official instructions prohibit disposing of the medicine in household waste or flushing it down the toilet. Instead, users must ask a pharmacist or local waste disposal company for information on how to discard it safely and responsibly.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Trigan found in:

A-Z Index: